CDER To Solicit PhRMA/BIO Input On Critical Path
This article was originally published in The Pink Sheet Daily
Executive Summary
Upcoming meetings will aid in streamlining the initiative while facilitating increased collaboration, deputy director Throckmorton says.
You may also be interested in...
FDA To Provide Updates On Agency Involvement In Critical Path Projects
Agency opportunities list highlights 76 “scientific projects” that could modernize the medical product development process.
Lipitor Pricing Offsets Loss In Prescription Volume, Pfizer Says
Declines in Lipitor's prescription volume due to the presence of generic simvastatin are being offset by price increases, Pfizer says
Mail-Order Pharmacy Not Necessarily Cheaper To Health Plans, Ohio Finds
Health plans should account for the rise in utilization that occurs with use of mail-order pharmacy when deciding if mail order saves money, Ohio Public Employees Retirement System Director of Healthcare Scott Streator said at the recent Academy of Managed Care Pharmacy Educational Conference in Chicago